Does Metformin Cause Hair Loss? What the Evidence Actually Shows

Metformin is one of the most prescribed medications in the world. It is first-line therapy for type 2 diabetes, a common adjunct in prediabetes, and one of the standard treatments for the metabolic features of polycystic ovary syndrome (PCOS). It also has decades of safety data behind it. When patients on metformin notice their hair shedding more than usual, the natural question is whether the drug itself is the cause. The evidence-based answer is nuanced: metformin is not directly toxic to hair follicles, but it can produce conditions that lead to shedding in a meaningful minority of users, most often through vitamin B12 depletion over time. This guide walks through what the evidence actually shows, the mechanism that links the two, and what to do if you are noticing increased shedding while on metformin.

What the evidence shows about metformin and hair

Hair loss is not listed as a common adverse event in the FDA prescribing information for metformin, and it was not a primary endpoint in the long-term outcome trials that established its use (FDA label, metformin hydrochloride). Case reports of hair shedding in metformin users exist in the dermatology literature, but they are uncommon and almost always describe a diffuse pattern consistent with telogen effluvium rather than a structural follicle problem.

The stronger and more reproducible link is indirect. Metformin reduces intestinal absorption of vitamin B12 in a meaningful percentage of long-term users. The Diabetes Prevention Program Outcomes Study found that 4.3% of patients on metformin developed B12 deficiency by year 5, compared with 2.3% on placebo, and borderline-low B12 was substantially more common in the metformin group (Aroda et al., J Clin Endocrinol Metab, 2016). Other observational studies have reported rates of low or borderline B12 as high as 10 to 30% in patients on metformin for several years (de Jager et al., BMJ, 2010).

B12 deficiency, when present, is one of the nutritional states associated with diffuse hair shedding. This is the mechanism most likely to explain the cases where shedding genuinely tracks with metformin use.

Why B12 depletion matters for hair

Vitamin B12 is required for the DNA synthesis that supports rapidly dividing cells, and the matrix cells of an active hair follicle are among the fastest-dividing populations in the body. When B12 falls low enough to affect erythropoiesis (the same reason a deficient patient develops megaloblastic anemia), it can also affect follicle function. The clinical result is usually a diffuse telogen effluvium: a synchronized shift of follicles into the resting phase, followed 2 to 4 months later by a noticeable shed.

The pattern matters. B12-related shedding is:

• Diffuse across the whole scalp, not concentrated at the crown or hairline.
• Often accompanied by other signs of low B12 (fatigue, pale skin, occasional tingling in the hands or feet, in more severe cases changes in balance or memory).
• Reversible once B12 is restored, with regrowth typically becoming visible 3 to 6 months after correction.

A fuller treatment of which deficiencies actually matter for hair is in the dedicated nutritional deficiencies guide. B12 is one of the better-supported entries on that list.

What about the rest of metformin's side effect profile?

Metformin's most common side effects are gastrointestinal: nausea, loose stools, abdominal discomfort, and a metallic taste. These usually improve over the first few weeks. They are worth flagging because, in patients who eat less while adjusting to the medication or who are also losing weight as a result of better glycemic control, the same physiologic stress that drives weight-loss-related shedding can be in play. The mechanism is the same one discussed in the guide on GLP-1 weight loss drugs and hair loss: rapid weight loss, reduced caloric intake, and lower iron or ferritin levels can each push follicles into telogen even when the drug itself is not toxic to the follicle.

So a patient who notices shedding 2 to 4 months after starting metformin and who has also lost meaningful weight, eaten less, or developed iron or B12 deficiency along the way may be experiencing a multi-factor telogen effluvium rather than a direct drug effect.

How to think about testing

If you are on metformin and noticing more shedding than usual, a focused workup is generally more useful than reaching straight for a supplement. The labs most worth discussing with a physician include:

• Serum B12 and methylmalonic acid (MMA). Serum B12 alone can miss functional deficiency, since metformin can interfere with absorption in a way that does not always show up in total B12 levels. MMA rises when B12 is functionally low and is a more sensitive marker.
• Ferritin and complete blood count. Iron deficiency commonly co-exists with B12 deficiency, particularly in women of reproductive age and in patients with PCOS. Ferritin under 30 ng/mL has been associated with worse hair loss outcomes in observational data (Trost et al., J Am Acad Dermatol, 2006).
• TSH. Thyroid disease is more common in patients with type 2 diabetes and PCOS than in the general population, and it produces a similar diffuse shed.
• Vitamin D, 25-OH. Often low in patients with metabolic disease and modestly associated with shedding when deficient.

This is the same workup a dermatologist would use for any patient presenting with diffuse, non-patterned shedding. The point is to identify the correctable causes rather than to layer supplements on top of an unknown.

What if the shedding is actually pattern hair loss?

PCOS in particular is associated with female pattern hair loss, driven by elevated androgens acting on genetically susceptible follicles. Metformin is often prescribed in this same population, which can create the impression that the medication is causing the hair loss when both are actually consequences of the underlying condition. The patterns are different:

• Telogen effluvium is diffuse, develops over months, and resolves when the trigger is corrected.
• Pattern hair loss is concentrated at the part line, the crown, or the frontal scalp, develops over years, and does not resolve without treatment.

Both can be present in the same patient. A scalp exam by a physician or dermatologist is the most reliable way to tell which is contributing. A summary of the underlying biology is in the androgenetic alopecia explainer.

How metformin-related shedding is typically managed

The standard approach is correction of the underlying cause plus supportive care, not stopping the medication:

• Restore B12 if deficient. Oral supplementation is usually sufficient even though metformin reduces absorption, because the doses used (1,000 to 2,000 mcg daily) overcome the deficit. Patients with severe deficiency or neurologic symptoms may need intramuscular B12. This should be guided by a physician, not self-prescribed indefinitely.
• Address iron and ferritin if low. Adequate protein intake and ferritin in a healthy range support follicle recovery.
• Time. Most telogen effluvium resolves within 6 to 9 months once the underlying trigger is corrected. Regrowth begins before the shed fully stops, so the scalp can look thin during the transition even when recovery is well underway.
• Continue the metformin in most cases. The metabolic benefits of metformin (glycemic control, cardiovascular risk reduction, PCOS symptom management) are large and well established. Stopping the medication because of shedding is rarely the right tradeoff, especially when correcting B12 addresses the proximate cause.

What this means if you're on metformin and shedding

The reasonable framing for a patient noticing more shedding while on metformin is to look first at whether B12 has drifted low, whether iron is adequate, and whether the pattern of shedding is diffuse (consistent with telogen effluvium) or patterned (consistent with androgenetic alopecia). Most cases resolve with B12 repletion and time. A minority will turn out to involve pattern hair loss that the metformin did not cause but the shedding episode made more visible. That is a separate condition with its own treatment options.

If you are noticing shedding on metformin and you also notice the loss is concentrated at the temples, the crown, or the part line rather than diffuse, that is worth a separate conversation about whether pattern hair loss is part of the picture. Curekey's hair assessment is one way to start that conversation with a U.S.-licensed physician.

Related reading

• Does Ozempic, Wegovy, or Mounjaro cause hair loss?: the sibling article on weight-loss medications, with overlapping mechanism.
• Nutritional deficiencies that cause hair loss: which deficiencies are actually linked to shedding and what testing is useful.
• Stress and hair loss: telogen effluvium: the cycle-based explanation for the most common cause of acute shedding.
• How minoxidil treats hair loss: the most common adjunctive treatment when shedding overlaps with pattern hair loss.
• How it works: what a Curekey assessment and physician review look like.